Last update 16 May 2025

MR-MC-01

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms-
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Urogenital DiseasesOther DiseasesNervous System Diseases+ [4]
Active Indication-
Inactive Indication
Cystitis, InterstitialDiabetic FootDiabetic Retinopathy
Originator Organization
Asan Medical CenterAsan Medical Center
Active Organization-
Inactive Organization
Asan Medical CenterAsan Medical CenterMirae Cell Bio Co., Ltd.Mirae Cell Bio Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
RegulationOrphan Drug (South Korea)
Login to view timeline

Related

3
Clinical Trials associated with MR-MC-01
KCT0009028
/ Not yet recruitingPhase 1/2
A single-center, phase 1/2a clinical trial to evaluate the safety, maximum tolerated dose, and exploratory efficacy of MR-MC-01 treatment in patients with underactive bladder
KCT0006999
/ RecruitingPhase 1/2
A single-center, phase 1/2a clinical trial to evaluate the safety, efficacy, and maximum tolerated dose of MR-MC-01 treatment in patients with interstitial cystitis
NCT04610359
/ Unknown statusPhase 1IIT
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis; Open-labelled, Single Center, Phase 1 Study
100 Clinical Results associated with MR-MC-01
Login to view more data
100 Translational Medicine associated with MR-MC-01
Login to view more data
100 Patents (Medical) associated with MR-MC-01
Login to view more data
100 Deals associated with MR-MC-01
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cystitis, InterstitialPhase 1
United States
Asan Medical CenterAsan Medical Center
20 Oct 2020
Diabetic FootPreclinical
South Korea
Mirae Cell Bio Co., Ltd.Mirae Cell Bio Co., Ltd.
02 Oct 2020
Diabetic RetinopathyPreclinical
South Korea
Mirae Cell Bio Co., Ltd.Mirae Cell Bio Co., Ltd.
01 Oct 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free